Bionomics Ltd (External organisation)

  • Flynn, B. L. (Inventor)
  • Dharam Paul (Inventor)
  • Andrew John Harvey (Inventor)

Activity: Industry, Government and Philanthropy Engagement and PartnershipsPatentsPatent


A crystalline form of an anxiolytic compound

Abstract: The present invention provides a crystalline Form B of compound 1, and pharmaceutically compositions thereof. The present invention also provides methods of treating a disease (e.g., a disease of the central nervous system) using the pharmaceutical compositions.

WO2014138772A1 - WIPO (PCT)
Application PCT/AU2013/000497 events
2013-03-15 Priority to US201361787436P
2013-03-15 Priority to US61/787,436
2013-04-12 Priority to AU2013204159
2013-04-12 Priority to AU2013204159A
2013-05-14 Application filed by Bionomics Limited
2014-09-18 Publication of WO2014138772A1

Related patent documents
AU2013204159 EP2970290 US20160039810 AU2013382559 JP2016510767 CN107814799 CA2905573 MX369451 NZ712341 US20170305905 JP2018109011
Held atBionomics Ltd, Australia, South Australia
Degree of RecognitionInternational